| Brett Shumway, | |
|
646 S Main St # 207, Cedar City, UT 84720-3549 | |
| (435) 327-0176 | |
| Not Available |
| Full Name | Brett Shumway |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 646 S Main St # 207, Cedar City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417483603 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 10042018-2501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brett Shumway, 996 Cedar Knls W, Cedar City, UT 84720-3631 Ph: (435) 327-0176 | Brett Shumway, 646 S Main St # 207, Cedar City, UT 84720-3549 Ph: (435) 327-0176 |
News Archive
Makdasi et al. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants. bioRxiv, 2021. doi: https://doi.org/10.1101/2021.04.01.438035, https://www.biorxiv.org/content/10.1101/2021.04.01.438035v2
A team of researchers from the National University of Singapore has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.
Axolotl Corp., the nationwide leader in health information exchange (HIE) solutions and services and Rochester RHIO, the regional health information organization connecting medical providers across nine counties in New York, today announced that six emergency departments are using Rochester RHIO to view critical patient information from data providers across the region. Emergency departments (ED) include Clifton Springs, F.F. Thompson, Lakeside Memorial, Rochester General, United Memorial Medical Center, and Wyoming Community Hospitals.
Using laboratory mice that had been bred to have brain changes similar to Alzheimer's disease, scientists were able to reduce two characteristic features of the disease by modifying the mice's immune systems with a special peptide (MOG45D) related to the myelin sheath that insulates nerve cells and nerve fibers. As a result, anti-inflammatory cells were recruited from the blood into the brain, dampening the local inflammatory response.
Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic researcher who co-led PERSIST-1, the worldwide phase III clinical trial that tested the therapy. Specifically, pacritinib substantially reduced severe enlargement of the spleen, a typical feature of advanced myelofibrosis, in more than 20 percent of patients and alleviated debilitating side effects in more than 46 percent.
› Verified 5 days ago
Curtis L Hill, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1921 W 546 S, Cedar City, UT 84720 Phone: 435-865-8225 | |
Dr. Melissa Leilani Devencenzi, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 732 S 2075 W, Cedar City, UT 84720 Phone: 951-264-0798 | |
Dr. Kirsten Leigh Graham, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 351 W University Blvdgeneral Classrooms 308-o, General Classrooms 308-o, Cedar City, UT 84720 Phone: 435-277-0285 | |
Steve T Barney, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 245 E 680 S, Cedar City, UT 84720 Phone: 435-867-7654 Fax: 435-986-8700 | |
Dr. William Sidney Young, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 747 S Paradise Canyon Rd, Suite 2, Cedar City, UT 84720 Phone: 435-865-9119 Fax: 435-865-9115 |